MCRB vs USB · rev $1.1M vs P/E 12, rev $7.71B
Seres Therapeutics Inc (MCRB) versus U.S. Bancorp (USB) — a side-by-side from cached financials, not a winner call.
Seres Therapeutics Inc (MCRB) is a biotechnology company listed on US.
U.S. Bancorp (USB) is a banks - regional company listed on US.
Latest reported MCRB revenue for 2026-06-30 was $1.1M. Net income was -$15.3M. MCRB currently screens at market cap $109.8M.
Latest reported USB revenue for 2026-06-30 was $7.71B. Net income was $2.18B. Revenue was up 5.8% from 2026-03-31 to 2026-06-30. USB currently screens at market cap $74.68B and trailing P/E 11.9.
MCRB currently screens at market cap $109.8M. USB currently screens at market cap $74.68B and trailing P/E 11.9.
Not investment advice. Open the MCRB and USB stock pages for the full models.
Not investment advice.